Current Rheumatology Reports

, Volume 5, Issue 5, pp 370–373

Evidence-based management of thrombosis in the antiphospholipid antibody syndrome

  • Michelle Petri
Article

DOI: 10.1007/s11926-003-0023-7

Cite this article as:
Petri, M. Curr Rheumatol Rep (2003) 5: 370. doi:10.1007/s11926-003-0023-7

Abstract

Recommendations for the management of thrombosis in the antiphospholipid antibody syndrome have been based largely on retrospective case series. Several clinical trials have been recently published on the management of thrombosis in general. Two clinical trials have specifically addressed thrombosis in antiphospholipid antibody syndrome, and one is underway. These new clinical trials have challenged the previous dogma of a target International Normalized Ratio of 3 to 4 (“high-intensity” warfarin).

Copyright information

© Current Science Inc. 2003

Authors and Affiliations

  • Michelle Petri
    • 1
  1. 1.Department of Medicine: RheumatologyJohns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations